AMADIX

amadix-logo

Amadix develops and commercializes breakthrough discoveries in cancer diagnosis with a clear commercial rationale, addressing unmet medical needs in oncology. After analytical validation and demonstration of clinical validity and utility through international multicentre studies, the products will be commercialized worldwide. The most advanced product developed by Amadix is Colofast, an innovative non-invasive screening signature for colorectal cancer (CRC) and advanced adenoma diagnosis in blo... od designed to solve a significant health priority: the high mortality rate due to colon cancer worldwide (around half of the diagnosed patients). Amadix team consist of industry veterans with robust expertise in the Oncology Diagnostic area. They are a top level management team with international experience in cancer diagnostics, the pharmaceutical industry, the biotechnology sector and intellectual property. Amadix also has independent board members with international profiles and many years of experience in oncology and diagnostics, who advise the management team on strategy, commercialization and business development in Europe and the US.

#SimilarOrganizations #People #Financial #Website #More

AMADIX

Social Links:

Industry:
Biopharma Biotechnology Health Care Life Science Medical Oncology Pharmaceutical

Founded:
2010-01-01

Address:
Madrid, Madrid, Spain

Country:
Spain

Website Url:
http://www.amadix.com

Total Employee:
11+

Status:
Active

Contact:
+34 983 10 20 60

Email Addresses:
[email protected]

Total Funding:
4.55 M EUR

Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Domain Not Resolving Euro Apple Mobile Web Clips Icon Google Font API Google Tag Manager WordPress Google Analytics Amazon


Similar Organizations

arctic-therapeutics-logo

Arctic Therapeutics

Arctic Therapeutics (AT) uses bioinformatic approaches and AI to eliminate major risks associated with traditional drug development.

avstera-therapeutics-logo

Avstera Therapeutics

Avstera Therapeutics is an oncology-focused biotech company that fulfil unmet needs of cancer patients.

carisma-therapeutics-logo

Carisma Therapeutics

Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.

european-network-of-gynecological-oncological-trial-groups-engot-logo

European Network of Gynecological Oncological Trial Groups (ENGOT)

ENGOT is a research network of the European Society of Gynaecological Oncology (ESGO).

externautics-logo

Externautics

Externautics is a biotech company exploiting possibilities for the identification and development of diagnostics for oncology applications.

eden-biologics-logo

Eden Biologics

Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.

liplasome-pharma-logo

LiPlasome Pharma

LiPlasome, a biotech company focused on oncology, provides a liplasomal reformulation of anticancer drugs on the market.

nephrodi-therapeutics-logo

NephroDI Therapeutics

NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.

piqur-therapeutics-logo

PIQUR Therapeutics

PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.

tcd-pharma-logo

TCD Pharma

TCD Pharma is a biotechnology company engaged in the discovery, development and commercialization of oncology drugs.


Current Advisors List

marina-rigau_image

Marina Rigau Member of the Board of Directors @ Amadix
Board_member

Current Employees Featured

rosa-pérez_image

Rosa Pérez
Rosa Pérez Research Scientist @ Amadix
Research Scientist

rocio-arroyo_image

Rocio Arroyo
Rocio Arroyo Chief Executive Officer @ Amadix
Chief Executive Officer
2010-10-01

ana-carmen-martín_image

Ana Carmen Martín
Ana Carmen Martín Scientific Director @ Amadix
Scientific Director

cristina-delgado_image

Cristina Delgado
Cristina Delgado Administrative Manager @ Amadix
Administrative Manager

lucía-reinoso_image

Lucía Reinoso
Lucía Reinoso Chief Financial Officer @ Amadix
Chief Financial Officer
2013-04-01

Founder


rocio-arroyo_image

Rocio Arroyo

Acquisitions List

Date Company Article Price
2013-02-10 Transbiomed Transbiomed acquired by Amadix N/A

Investors List

european-innovation-council_image

European Innovation Council

European Innovation Council investment in Grant - Amadix

spain-tech-center_image

Desafia

Desafia investment in Non Equity Assistance - Amadix

easme_image

EASME - EU Executive Agency for SMEs

EASME - EU Executive Agency for SMEs investment in Grant - Amadix

clave-mayor_image

Clave Mayor

Clave Mayor investment in Venture Round - Amadix

crb-inverbo_image

CRB Inverbío

CRB Inverbío investment in Venture Round - Amadix

inveready-technology-investment-group_image

Inveready

Inveready investment in Venture Round - Amadix

Official Site Inspections

http://www.amadix.com Semrush global rank: 7.4 M Semrush visits lastest month: 779

  • Host name: vps32.gestiondns.eu
  • IP address: 178.33.112.36
  • Location: Spain
  • Latitude: 40.4172
  • Longitude: -3.684
  • Timezone: Europe/Madrid

Loading ...

More informations about "Amadix"

Amadix - Crunchbase Company Profile & Funding

Amadix develops and commercializes breakthrough discoveries in cancer diagnosis with a clear commercial rationale, addressing unmet medical needs in oncology. After analytical validation and demonstration of clinical validity and …See details»

International experience in cancer diagnostics - Amadix

Rocío Arroyo is specialized in the management of innovative companies in early cancer detection, with a background in Medical Device, Diagnostics and Biopharmaceuticals. She has dedicated …See details»

Molecular Diagnostics Company - Amadix

To this end, Amadix collaborates with research groups from around the world to identify and develop next-generation biomarkers for cancer diagnostics. Amadix was the winning …See details»

Amadix - Funding, Financials, Valuation & Investors - Crunchbase

Feb 10, 2013 Amadix is a biotechnology company focused on the development and commercialization of diagnostic tools for personalized oncology treatment. Search …See details»

Amadix - Contacts, Employees, Board Members, Advisors

Organization. Amadix . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 5. Number of Board …See details»

Amadix - Company Profile - Tracxn

Dec 19, 2024 Amadix. has raised a total funding of $6.87M over 8 rounds. Its first funding round was on Feb 10, 2013. What are the most recent funding rounds of Amadix? Its latest funding …See details»

Amadix - CoBee Company Profile & Funding Rounds

Amadix develops and commercializes breakthrough discoveries in cancer diagnosis with a clear commercial rationale, addressing unmet medical needs in oncology. After analytical validation …See details»

Amadix - Overview, News & Similar companies | ZoomInfo.com

Jan 23, 2024 Who is Amadix. Amadix is a biotechnology company developing innovative diagnostic tools in oncology, either to support the physician's decisions for administratio n of …See details»

Amadix - Products, Competitors, Financials, Employees, …

Amadix. Frequently Asked Questions (FAQ) When was Amadix founded? Amadix was founded in 2010. Where is Amadix's headquarters? Amadix's headquarters is located at Recoletos …See details»

Investors - Amadix

Investors Amadix A unique investment opportunity. Amadix is focused on early cancer detection by using state-of-the-art liquid biopsy. To extend people’s lives, the company develops and …See details»

Amadix Company Overview, Contact Details & Competitors | LeadIQ

Liquid Biopsy Expertise Amadix is a leading molecular diagnostics company specializing in liquid biopsy, offering a unique opportunity to target clients seeking innovative cancer detection …See details»

Amadix | AseBio - Asociación Empresas Biotecnología

Founded in 2010, Amadix is a leading molecular diagnostics company focused on developing innovative diagnostic tests for early cancer detection in blood to improve patient survival and …See details»

FDA Grants Breakthrough Device Designation to Amadix´s

Jan 23, 2024 About Amadix. AMADIX is a leading molecular diagnostics company focused on liquid biopsy, developing innovative diagnostic tests for early cancer detection in blood. ...See details»

Amadix - Crunchbase

Amadix is a biotechnology company focused on the development and commercialization of diagnostic tools for personalized oncology treatment. Search Crunchbase. Start Free Trial . …See details»

Amadix Employee Directory, Headcount & Staff | LeadIQ

Amadix Employee Directory . Biotechnology Research Castilla y León, Spain 11-50 Employees. AMADIX is a leading molecular diagnostics company focused on liquid biopsy, developing …See details»

Executive Summary - 2016 - Amadix

AMADIX Executive Summary - 2016 NON-CONFIDENTIAL This document is an introduction to Advanced Marker Discovery, S.L., (“Amadix” or the “Company”) and is not an offer to sell, or a …See details»

Amadix Company Information - Funding, Investors, and More

The company Amadix has raised a total of $3.76m in funding over 1 rounds. Key Insights: Unknown: $3.76m; 2019. Amadix Unknown (2019, $3M) $3.76m. Discover Iwoca. Company …See details»

Amadix Company Profile: Funding, Investors & Partnerships

Amadix. Submit feedback Claim this profile. AMADIX is a leading molecular diagnostics company focused on liquid biopsy, developing innovative diagnostic tests for early cancer detection in …See details»

Amylyx Pharmaceuticals Appoints Dan Monahan as Chief …

20 hours ago CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (“Amylyx” or the “Company”) today announced the appointment of Dan …See details»

Rocío Arroyo, CEO of Amadix, has been chosen as one of the …

This year, the specialized magazine has selected 22 people, including Rocío Arroyo, who stand out for their talent, leadership, productivity, and power to change the world. Rocío Arroyo has …See details»

linkstock.net © 2022. All rights reserved